Creativ-Ceutical (France)

Recent papers from Creativ-Ceutical (France)

1. Reducing Domain-Specific Hallucinations in LLMs via Expert Context Injection without Model Retraining: A Governed Inference Framework and Controlled Ablation Study2026
2. Synthesis of zinc and boron nano particles and evaluating their effects on the physiological, biochemical and agronomical aspects of cauliflowerJournal of Plant Nutrition · 2026
3. Aspirin twice a day and acute coronary syndrome: The ANADAMN trialArchives of cardiovascular diseases · 2026
4. Cost-effectiveness of finerenone therapy for patients with chronic kidney disease and type 2 diabetes in England & Wales: results of the FINE-CKD modelJournal of Medical Economics · 2025
5. Exit interviews from two randomised placebo-controlled phase 3 studies with caregivers of young children with autism spectrum disorderFrontiers in Child and Adolescent Psychiatry · 2024
6. Public Health Impact and Cost-Effectiveness of Empagliflozin (JARDIANCE®) in the Treatment of Patients with Heart Failure with Preserved Ejection Fraction in France, Based on the EMPEROR-Preserved Clinical TrialPharmacoEconomics - Open · 2023
7. Hyperhidrosis: A targeted literature review of the disease burdenThe Journal of Dermatology · 2023
8. Intravascular Ultrasound Guidance During Peripheral Vascular Interventions: Long-term Clinical Outcomes and Costs From the Japanese PerspectiveJournal of Endovascular Therapy · 2023
9. Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysisFrontiers in Oncology · 2023
10. Disease Impact and Cost-Effectiveness of a New Dengue Vaccine Tak003 in ThailandInternational Journal of Infectious Diseases · 2023
11. Recommendations for economic evaluations of cell and gene therapies: a systematic literature review with critical appraisalExpert Review of Pharmacoeconomics & Outcomes Research · 2023
12. Achievement Rates for Low-Density Lipoprotein Cholesterol Goals in Patients at High Risk of Atherosclerotic Cardiovascular Disease in a Real-World Setting in JapanJournal of Atherosclerosis and Thrombosis · 2023
13. Valuation of Treatments for Rare Diseases: A Systematic Literature Review of Societal Preference StudiesAdvances in Therapy · 2022
14. Real-world evidence for steroidal mineralocorticoid receptor antagonists in patients with chronic kidney diseaseJournal of Nephrology · 2022
15. Economic evaluation of encorafenib with cetuximab in patients with BRAF V600E-mutant metastatic colorectal cancer in France: a cost-effectiveness analysis using data from the BEACON CRC randomised controlled trialBMJ Open · 2022
16. Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world dataCephalalgia · 2022
17. Impact of the COVID-19 pandemic on the conduct of clinical trials: a quantitative analysisJournal of Market Access & Health Policy · 2022
18. Validation of the FINE-CKD model for future health technology assessments for finerenone in patients with chronic kidney disease and type 2 diabetesThe American Journal of Managed Care · 2022
19. Epidemiology, treatment and burden of Wilson disease in France: A 10-year analysis of the national health insurance databaseClinics and Research in Hepatology and Gastroenterology · 2022
20. iStent inject® and cataract surgery for mild-to-moderate primary open angle glaucoma in Japan: a cost-utility analysisInternational Journal of Ophthalmology · 2022